1st European Ovary Workshop: Venues

EMBO Workshop on Ovarian Biology:
1st European Ovary Workshop
All About Ovaries

arrow_back View All Dates

TBA

09:00 • Keynote: In vitro maturation of immature oocytes in women with PCOS
09:30 • The effect of chronic inflammation on female fertility, oocyte epigenetics, and oocyte quality
09:45 • TUBB8 mutations and oocyte immaturity: screening, IVF outcomes and therapeutical perspectives : a systematic review
09:45 • Mesenchymal stromal cell secretome and its evaluation in the treatment of Polycystic Ovary Syndrome
09:45 • Mild chronic variable stress promotes female fertility via the ovarian CRF receptor
09:45 • The power of near-infrared photobiomodulation therapy on rescue in vitro maturation of human oocytes
09:45 • An investigation of the genetic association between low ovarian reserve and female malignancy
09:45 • Challenges in managing FOXL2-related follicular arrest: when modern IVF and tissue preservation fall short
09:45 • Follicular fluid concentrations of the vitamin D metabolite 24,25(OH)2D3 are positively associated with live birth rate after ART
10:15 • Break
10:45 • Keynote: Assessing toxicity in human ovaries - from exposures and epidemiology to in vitro models
11:15 • Impact of cannabis on human oocytes and IVF outcomes: an extensive in vitro and clinical investigation
11:30 • Scoping review of the association between ultra-processed food and female fertility: current evidence and research gaps
11:30 • Perinatal exposure to Bisphenol A impairs the ovarian follicle dynamics and its extracellular milieu
11:30 • Repercussions of estrogen replacement therapy against BPA-induced ovarian disruption in a rodent model
11:30 • Effects of phthalates on the 3D spheroid cell culture as a model for the human ovarian extracellular matrix
11:30 • Single-cell insights on the effects of the phthalate metabolite MEHP on the human ovary in vitro
11:30 • Cannabis alters human granulosa cell steroidogenesis and luteinization
11:30 • Secondary effects of thyroid hormone disrupting chemicals on the ovary transcriptome – identification of effect biomarkers
11:30 • Hypo- and Hyper-methylation in oocytes correlates with altered folliculogenesis following exposure to an estrogenic endocrine disruptor
12:00 • Impact of maternal aging on oocyte DNA repair and female fertility
12:00 • Generation of functional oocytes by sex chromosome correction in vitro
12:00 • Investigating ribosome dynamics in the aging mammalian oocyte
12:00 • The Multispecies Ovary Tissue Histology Electronic Repository (MOTHER): A resource for science, education and data sharing
13:00 • Lunch
14:30 • Keynote: New insights to ovarian tissue cryopreservation and transplantation
15:00 • Ovarian tissue after thawing: metabolic recovery and hormonal effects in follicle preservation, apoptosis and angiogenesis
15:30 • Optimization of freezing and thawing protocols for human ovarian tissue cryopreservation through thermophysical characterisation of freezing medium by Differential Scanning Calorimetry
15:30 • Can UCMSCs improve the integrity and mitochondrial function of cryopreserved ovarian grafts?
15:30 • Antioxidant potential of eugenol derivatives: a preliminary study for ovarian tissue cryopreservation
15:30 • Effect of prolonged cooling on metabolism of ovarian tissues in transport: TOM20 as a biomarker of mitochondrial function
15:30 • Biomechanical assessment of human ovarian cortex after vitrification and slow freezing procedures
15:30 • Molecular regulation of in vitro matured human oocytes in connection with ovarian tissue cryopreservation
15:30 • Evaluating follicular outcomes during ex vivo photodynamic therapy in ovarian tissue
15:30 • Effect of freezing and culturing ovarian tissue on follicle development in prepubertal girls
15:30 • A novel platform for cutting-edge cancer research is a tumor-infiltration mimicking model of contaminated ovarian tissue
15:30 • Optimization of ovarian tissue transplantation through biomaterials: a scoping review
15:30 • What is the impact of transport time on the quality of ovarian tissue prior to cryopreservation? A comparison of post-transplantation success rates with findings at the proteomic, gene expression and histological levels
15:30 • Circulating cell-free DNA and miR 502-3p are new predictive biomarkers of fertility preservation outcome in patients with breast cancer
16:15 • Break
16:45 • Activation or Apoptosis: Combined suppression of intrinsic and extrinsic follicle activation pathways completely prevents cyclophosphamide-induced follicle loss, while DNA damage doesn't end in oocyte apoptosis
17:00 • Clinical and ethical perspectives of performing ovarian stimulation and oocyte cryopreservation in adolescents: 6 years experience from a tertiary centre
17:00 • Evaluating the gonadotoxicity of carboplatin and paclitaxel exposure on the ovary from young breast cancer patients carrying a BRCA mutation
17:00 • Fertility preservation for girls undergoing cancer treatments or other gonadal toxic therapies
17:00 • Use of long-acting GnRH trigger for fertility preservation patients
17:00 • Molecular and functional impact of X-ray on primary ovarian cells
17:00 • The protective effects of Aloe vera extract against doxorubicin-induced degeneration in mice ovarian follicles and stromal cells
17:00 • Use of factors released from human adipose stem cells for ovarian tissue regeneration
17:00 • Anti-Mullerian hormone protects human ovarian follicles and stromal cells from immediate and sustained cyclophosphamide-induced damage in vitro
17:00 • From Storage to Survivorship: Exploring the Experiences and Needs of Childhood Cancer Survivors with Stored Ovarian Tissue
17:30 • Keynote: Harmony in diversity – ovarian biology in wild animal species
18:00 • Poster Session 2 + Drinks
20:00 • Gala Dinner